[13C, 15N2]-5'-Deoxyfluorouridine

[13C, 15N2]-5'-Deoxyfluorouridine is a modified form of the chemotherapy drug 5-Fluorouracil, which is commonly used in the treatment of various types of cancer. This modified version of the drug contains two stable isotopes, carbon-13 and nitrogen-15, which can be used for metabolic labeling and tracing studies. The addition of carbon-13 and nitrogen-15 isotopes to the drug allows researchers to track its behavior within cells and tissues, providing valuable insight into its mechanism of action and potential side effects. This can help improve the effectiveness and safety of the drug for cancer patients. Chemically, [13C, 15N2]-5'-Deoxyfluorouridine is a nucleoside analogue that inhibits the synthesis of DNA and RNA, which are essential for cancer cell growth and proliferation. It is incorporated into the DNA and RNA of cancer cells, disrupting their replication and leading to cell death. The usage of [13C, 15N2]-5'-Deoxyfluorouridine is primarily for research purposes, particularly in the field of cancer biology. It is not currently approved for clinical use in humans, although its potential as a diagnostic tool and therapeutic agent is currently being explored. Overall, [13C, 15N2]-5'-Deoxyfluorouridine is a valuable tool for cancer researchers seeking to better understand the mechanisms of cancer and develop more effective treatments for this devastating disease.